Metronomic Capecitabine in Advanced Hepatocellular Carcinoma Patients: A Phase II Study

BACKGROUND. Anti-angiogenic treatment with targeted agents is effective in advanced hepatocellular carcinoma (HCC). This trial evaluated the safety and efficacy of metronomic capecitabine in patients with HCC. METHODS. This single-institution phase II trial included 59 previously untreated patients...

詳細記述

保存先:
書誌詳細
主要な著者: Brandi, Giovanni, de Rosa, Francesco, Agostini, Valentina, di Girolamo, Stefania, Andreone, Pietro, Bolondi, Luigi, Serra, Carla, Sama, Claudia, Golfieri, Rita, Gramenzi, Annagiulia, Cucchetti, Alessandro, Pinna, Antonio Daniele, Trevisani, Franco, Biasco, Guido
フォーマット: Artigo
言語:Inglês
出版事項: AlphaMed Press 2013
主題:
Clinical Trial Results
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3868418/
https://ncbi.nlm.nih.gov/pubmed/24232581
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2013-0093
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料